Enhance the standard of care for sepsis — by detecting bloodstream infections sooner

The T2Bacteria® Panel is the first and only FDA-cleared and CE-marked panel to detect five clinically relevant bacterial pathogens in 3 to 5 hours, directly from a whole blood sample. E. faecium, S. aureus, K. pneumoniae, P. aeruginosa, and E. coli represent the majority of bacteremia seen in the emergency department and those causing hospital-acquired infections. In addition, several of these species are known as ESKAPE pathogens, characterized as virulent and difficult to treat with empiric antimicrobial therapy, making faster species identification and targeted treatment critical to improving patient outcomes.